In lung, the total expression of ABO and GBAP1 had MR evidence with high colocalization (a posterior probability >0.8) for COVID-19 outcomes (all three COVID-19 outcomes with ABO and reported infection with GBAP1, Supplementary Data 7). This evidence concerns the gene ABO and COVID-19.